Cathelicidins Mitigate Staphylococcus aureus Mastitis and Reduce Bacterial Invasion in Murine Mammary Epithelium
- 22 June 2020
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 88 (7)
- https://doi.org/10.1128/iai.00230-20
Abstract
Staphylococcus aureus, an important cause of mastitis in mammals, is becoming increasingly problematic due to the development of resistance to conventional antibiotics. The ability of S. aureus to invade host cells is key to its propensity to evade immune defense and antibiotics. This study focused on functions of cathelicidins, small cationic peptides secreted by epithelial cells and leukocytes, in the pathogenesis of S. aureus mastitis in mice. We determined that endogenous murine cathelicidin (CRAMP; Camp) was important in controlling S. aureus infection, as cathelicidin knock-out mice (Camp-/-) intramammarily challenged with S. aureus had a higher bacterial burden and more severe mastitis than wild-type mice. Exogenous administration of both synthetic human cathelicidin (LL-37) and synthetic murine cathelicidin (CRAMP) (8 μM), reduced invasion of S. aureus into murine mammary epithelium. Additionally, this exogenous LL-37 was internalized into cultured mammary epithelial cells and impaired S. aureus growth in vitro. We concluded that cathelicidins may be potential therapeutic agents against mastitis; both endogenous and exogenous cathelicidins conferred protection against S. aureus infection by reducing bacterial internalization and potentially by directly killing this pathogen.Keywords
Funding Information
- Eyes High International Collaborative Grant
- Dairy Research Cluster 3 Canada
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPAS-2017- 507827)
This publication has 90 references indexed in Scilit:
- Cell density during differentiation can alter the phenotype of bone marrow-derived macrophagesCell & Bioscience, 2013
- The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated DiseasePLOS ONE, 2012
- Entamoeba histolytica Induces Intestinal Cathelicidins but Is Resistant to Cathelicidin-Mediated KillingInfection and Immunity, 2012
- Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37PLOS ONE, 2011
- Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006Journal of Public Health, 2009
- Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidinJournal of Leukocyte Biology, 2009
- Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsisJournal of Translational Medicine, 2009
- Differing effects of exogenous or endogenous cathelicidin on macrophage toll‐like receptor signalingImmunology & Cell Biology, 2009
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- CD36 is a sensor of diacylglyceridesNature, 2005